Stocktoria
Trevi Therapeutics, Inc. TRVI
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2019-05-07
Trevi Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 3,198,644 | $40.0M | 2.37% |
| CITADEL ADVISORS LLC | 1,353,389 | $16.1M | 1% |
| BlackRock Finance, Inc. | 3,135,115 | $9.3M | 2.33% |
| MILLENNIUM MANAGEMENT LLC | 570,971 | $6.8M | 0.42% |
| D. E. Shaw & Co., Inc. | 181,344 | $2.2M | 0.13% |
| TWO SIGMA INVESTMENTS, LP | 38,415 | $458,291 | 0.03% |
| AQR CAPITAL MANAGEMENT LLC | 28,149 | $335,817 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.